Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among...
from NDTV News - India-news https://ift.tt/3HTxies
Search This Blog
- January 202422
- December 202320
- November 202325
- October 202335
- September 202360
- August 202338
- July 202329
- June 202332
- May 202359
- April 202342
- March 202356
- February 202356
- January 202355
- December 202232
- November 202251
- October 202248
- September 202267
- August 202239
- July 202238
- June 202255
- May 2022110
- April 2022116
- March 2022129
- February 2022101
- January 2022114
- December 2021321
- November 2021657
- October 2021682
- September 2021657
- August 2021713
- July 2021713
- June 2021693
- May 2021703
- April 2021690
- March 2021713
- February 2021644
- January 2021724
- December 2020708
- November 2020694
- October 2020617
Labels
MAIN MENU
3/recent/post-list
Footer Menu Widget
Created by Website Designer In India | Distributed by Blogger Templates
0 Comments